Philip Morris sets $1.47 quarterly dividend
Philip Morris International Inc. declared a regular quarterly dividend of $1.47 per common share.
Rhea-AI Filing Summary
Philip Morris International Inc. declared a regular quarterly dividend of $1.47 per common share. The dividend will be paid on April 13, 2026 to shareholders of record as of March 19, 2026, which is also the ex-dividend date. The company highlights its strategy of growing smoke-free products, which accounted for 41.5% of its full year 2025 total net revenues, and notes that over 43 million legal-age consumers were using its smoke-free products as of December 31, 2025.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 7.01, 9.01
2 items
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
FAQ
What dividend did Philip Morris International (PM) declare in this 8-K?
Philip Morris International declared a regular quarterly dividend of $1.47 per common share. The payment is scheduled for April 13, 2026, and goes to shareholders of record as of March 19, 2026, which is also the ex-dividend date noted in the disclosure.
When is the record date and payment date for Philip Morris (PM) $1.47 dividend?
The dividend is payable on April 13, 2026, to shareholders of record as of March 19, 2026. The ex-dividend date is also March 19, 2026, meaning investors must own shares before that date to receive the $1.47 per share payment.
How significant are smoke-free products in Philip Morris International’s (PM) 2025 revenues?
Smoke-free products contributed 41.5% of Philip Morris International’s full year 2025 total net revenues. These include heat-not-burn, nicotine pouch and e-vapor products, reflecting the company’s strategic shift toward a smoke-free portfolio alongside its traditional cigarette business globally.
How many consumers use Philip Morris International’s smoke-free products?
As of December 31, 2025, Philip Morris International estimates over 43 million legal-age consumers used its smoke-free products. Many of these consumers have moved away from cigarettes or reduced cigarette consumption, illustrating ongoing adoption of the company’s alternative nicotine offerings worldwide.
How much has Philip Morris (PM) invested in smoke-free product development?
Since 2008, Philip Morris International has invested over $16 billion in developing, scientifically substantiating and commercializing smoke-free products. This spending covers product innovation, scientific assessment capabilities, clinical and behavioral research, and post-market studies to support alternatives for adults who would otherwise continue smoking.
What FDA authorizations have Philip Morris and Swedish Match products received?
The U.S. FDA has authorized marketing of Swedish Match’s General snus and ZYN nicotine pouches, plus versions of PMI’s IQOS devices and consumables. Certain IQOS and General snus products have also received the first-ever Modified Risk Tobacco Product authorizations in their respective categories.
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 5, 2026
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||||
| (Address of principal executive offices) | (Zip Code) | ||||||||||||||||
Registrant's telephone number, including area code: (203 ) 905-2410
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). | |||||
Emerging growth company | |||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ | ||||
| Item 7.01. | Regulation FD Disclosure. | ||||
On March 5, 2026, Philip Morris International Inc. issued a press release announcing that its Board of Directors declared a regular quarterly dividend of $1.47 per common share, which press release is attached as Exhibit 99.1 to this Item 7.01 of this Current Report on Form 8-K and incorporated by reference herein.
In accordance with General Instruction B.2 of Form 8-K, the information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in Item 7.01 of this Current Report on Form 8-K shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as may be expressly set forth by specific reference in such filing or document.
| Item 9.01. | Financial Statements and Exhibits. | ||||
| (d) | Exhibits. | ||||
| 99.1 | Philip Morris International Inc. Press Release, dated March 5, 2026 (furnished pursuant to Item 7.01). | ||||
| 104 | Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document and contained in Exhibit 101) | ||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| PHILIP MORRIS INTERNATIONAL INC. | ||||||||
| By: | /s/ DARLENE QUASHIE HENRY | |||||||
| Name: | Darlene Quashie Henry | |||||||
| Title: | Vice President, Associate General Counsel & Corporate Secretary | |||||||
Date: March 5, 2026
Exhibit 99.1
| PRESS RELEASE |  | |||||||||||||
| Investor Relations: | Media: | |||||||||||||
Email: InvestorRelations@pmi.com | Email: Corey.Henry@pmi.com | |||||||||||||
| Stamford, CT: +1 (203) 905 2413 | Stamford, CT: +1 (203) 905 2410 | |||||||||||||
| Lausanne: +41 582 424 500 | ||||||||||||||
Philip Morris International
Declares Regular Quarterly Dividend of $1.47 Per Share
Declares Regular Quarterly Dividend of $1.47 Per Share
STAMFORD, CT, March 5, 2026 – The Board of Directors of Philip Morris International Inc. (NYSE: PM) today declared a regular quarterly dividend of $1.47 per common share, payable on April 13, 2026, to shareholders of record as of March 19, 2026. The ex-dividend date is March 19, 2026. For more details on stock, dividends and other information, see www.pmi.com/dividend.
Philip Morris International: A Global Smoke-Free Champion
Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company’s current product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, nicotine pouch and e-vapor products. Our smoke-free products are available for sale in over 105 markets, and as of December 31, 2025 PMI estimates they were used by over 43 million legal-age consumers around the world, many of whom have moved away from cigarettes or significantly reduced their consumption. The smoke-free business accounted for 41.5% of PMI’s full year 2025 total net revenues. Since 2008, PMI has invested over $16 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. Following a robust science-based review, the U.S. Food and Drug Administration has authorized the marketing of Swedish Match’s General snus and ZYN nicotine pouches and versions of PMI’s IQOS devices and consumables - the first-ever such authorizations in their respective categories. Versions of IQOS devices and consumables and General snus also obtained the first-ever Modified Risk Tobacco Product authorizations from the FDA. With a strong foundation and significant expertise in life sciences, PMI has a long-term ambition to expand into wellness areas. References to “PMI”, “we”, “our” and “us” mean Philip Morris International Inc., and its subsidiaries. For more information, please visit www.pmi.com and www.pmiscience.com.